ArticleArchives of orthopaedic and trauma surgery2025
Pseudotumor following total hip arthroplasty: experience of a tertiary referral center and proposal of the new "PCS" classification system.
Article in Archives of orthopaedic and trauma surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Revision total hip arthroplasty for osteolysis and metallosis 17 years post-THA: a case report and literature review.International journal of surgery case reports · 2026Article
- Inflammatory Pseudotumor After Total Hip Arthroplasty-An Increasingly Recognized Complication.Orthopaedic surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis study summarizes outcomes in treating pseudotumors of the hip at a tertiary referral center and introduces a classification system to aid treatment decisions and enhance communication among providers. MATERIALS AND
methodsWe collected data from 39 patients who underwent surgery for hip pseudotumor, analyzing implant failures based on patient history, revision reasons, bearing surface type, mass location and size, bone loss, revision type, and whether it was single- or two-stage. We introduce the PCS classification: 'P' for Pseudotumor (with 's' for symptomatic, 'e/I' for intra/extrapelvic location, and 'm' for high Chromium/Cobalt levels), 'C' for implant status, and 'S' for bone loss extent. In 37 patients, we evaluated Cohen's kappa coefficient to evaluate interobserver reliability.
resultsTwenty (51.2%) patients were female, with a mean age of 71 years (range 36-89; σ 12.11); the mean follow-up duration was 54.43 months (range 12.2-128.3). The average size of the pseudotumor was 13.10 cm (range 3.3-37.2; σ 7.11) with 61.5% exhibiting extra-pelvic localization only. Bearing surfaces were MoM in 27 patients (69.2%). Single-stage revision surgery was performed in 87.1% of patients. There were 7 (17.9%) implant failures. No significant differences in failure rates were observed based on considered parameters. The agreement following Cohen's coefficient for the combined PCS classification was k = 0.43. Moderate to almost perfect agreement was obtained for parameter P and S, with k = 0.48 for parameter C.
conclusionNo correlation was found between failures and analyzed characteristics. Our classification assesses clinical scenarios and stratifies surgical complexity for indication purposes. While interobserver agreement varies with parameter C, it is consistent with parameters P and S.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.